Kera Capital Partners, Inc. Merck & Co., Inc. Transaction History
Kera Capital Partners, Inc.
- $347 Billion
- Q4 2024
A detailed history of Kera Capital Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 3,570 shares of MRK stock, worth $319,515. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,570Holding current value
$319,515% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,952Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.23 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.48 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $227B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...